Live feed
·
INSIDERFiling
Verona Pharma plc logo

Director Ackermann Christina returned 136,072 units of Ordinary Shares to the company and converted options into 72,000 units of Ordinary Shares, closing all direct ownership in the company (SEC Form 4)